| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $3.6B | $3.5B | $2.2B | $3.0B | $4.2B | $1.4B | $0.7B | $0.8B |
| EPS (Basic) | $9.38 | $8.64 | $5.21 | $6.19 | $7.40 | $2.28 | $1.15 | $1.09 |
| EPS (Diluted) | $9.28 | $8.55 | $5.19 | $6.15 | $7.34 | $2.27 | $1.15 | $1.09 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $119.1B | $119.5B | $117.5B | $104.6B | $95.7B | $95.9B | $104.8B | $106.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $15.0B | $14.7B | $14.3B | $10.3B | $8.3B | $11.5B | $12.1B | $9.4B |
| Total Liabilities | $102.3B | $102.9B | $103.6B | $91.7B | $82.1B | $83.2B | $89.7B | $92.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $16.8B | $16.6B | $13.9B | $12.9B | $13.7B | $12.7B | $15.1B | $14.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $9.9B | $9.8B | $8.6B | $6.7B | $7.1B | $7.5B | $9.0B | $9.3B |
| Investing Cash Flow | $-4.9B | $-8.9B | $-14.2B | $-10.2B | $-4.8B | $-0.5B | $-0.3B | $-19.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-4.7B | $-0.6B | $9.6B | $5.3B | $-5.2B | $-8.0B | $-6.5B | $8.3B |